Biblio
4 resultats trouvés
Filtres: Mot-clé is anti-IL-17 [Clear All Filters]
.
2020. Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis. IMMUNOTHERAPY. 12:857-860.
.
2020. From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition. EXPERT OPINION ON BIOLOGICAL THERAPY. 20:837-840.
.
2020. From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition. EXPERT OPINION ON BIOLOGICAL THERAPY. 20:837-840.
.
2019. New targeted therapies in spondyloarthritis: what are the limits? IMMUNOTHERAPY. 11:557-560.